Product of the month


• Primary carnitine deficiency: skeletal and cardiac muscle myopathy, hepatic encephalopathy.
• Secondary carnitine deficiency due to genetically determined disorders, acidurias and disorders of beta-oxidation.
• Secondary carnitine deficiency due to acquired conditions : Haemodialysis and Renal fanconi syndrome, Anticonvulsants: Sodium valproate, Pivampicilline therapy.
• Idiopathic asthenozoospermia.
• L-carniitne has a cardioprotective effect during antineoplastic therapy.
• Myocardial infarction: L-carniitne decreases the infarct size.
• Improve athletic performance in healthy subjects.
• Long standing leg ulcers.
• Hemolytic anemia (Thalassaemia & Sickle cell anemia).


1-3 tablets daily during meals or as directed by the physician.
powered by
copyright Mepaco-Medifood | Facebook Page